Skip to main content
. 2022 Jun 15;2022:4351949. doi: 10.1155/2022/4351949

Figure 1.

Figure 1

Expression of folate receptor 4 (FR4) in tumor-infiltrating lymphocytes (TILs) of esophageal squamous cell carcinoma (ESCC) patients from this study with IHC. FR4+ TILs (a and b) FR4-, (c) IgG isotype control, and (d) in ESCC patients.